James Sunter Muecke, AM

Dr. James Sunter Muecke, AM


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2006 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
JKJ J Khong
J J Khong
JAJames Sunter Muecke, AM
James Sunter Muecke, AM
Aim: To determine the complications associated with mitomycin C (MMC) in the treatment of ocular surface neoplasia. Methods: A retrospective and consecutive study of 100 eyes in 91 patients with ocular surface neoplasia treated with MMC in a single centre between November 1998 and January 2005. Outcome measures included complications of MMC and the treatment required for these complications. Results: One to three 7 day cycles of topical MMC 0.04% four times a day were given to 59 eyes with localised corneal-conjunctival intraepithelial neoplasia (CIN), 19 eyes with diffuse CIN, six eyes with recurrent CIN, one eye with ocular surface squamous cell carcinoma, three eyes with primary acquired melanosis (PAM) with atypia, nine eyes with conjunctival malignant melanoma (MM), two eyes with sebaceous carcinoma with pagetoid spread, and one eye with recurrent atypical fibroxanthoma. Nine patients had bilateral CIN. 31 (34%) cases developed an allergic reaction to MMC and 14 (14%) eyes had epiphora secondary to punctal stenosis at a mean follow up period of 26.5 months. Conclusion: In the largest study looking at complications of topical MMC in the treatment of ocular surface neoplasia, allergic reaction and punctal stenosis are relatively common. Serious complications were not observed suggesting the safe use of MMC in mid-term follow up.

13 April 2008 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
JAJames Sunter Muecke, AM
James Sunter Muecke, AM
HNHenry S Newland
Henry S Newland
PRPhilip Ryan
Philip Ryan
EREmmae Ramsay
Emmae Ramsay
MAMya Aung
Mya Aung
DSDinesh Selva
Dinesh Selva

8 December 2009 in Ophthalmic Epidemiology
Verified
Journal Article
Closed access
PDF file
JAJames Sunter Muecke, AM
James Sunter Muecke, AM
MHMichael Hammerton
Michael Hammerton
YAYee Yee Aung
Yee Yee Aung
SWSunil Warrier
Sunil Warrier
AKAimee Kong
Aimee Kong
DSDinesh Selva
Dinesh Selva
Purpose: To determine the causes of visual impairment and blindness amongst children in schools for the blind in Myanmar; to identify the avoidable causes of visual impairment and blindness; and to provide spectacles, low vision aids, orientation and mobility training and ophthalmic treatment where indicated. Methods: Two hundred and eight children under 16 years of age from all 7 schools for the blind in Myanmar were examined and the data entered into the World Health Organization Prevention of Blindness Examination Record for Childhood Blindness (WHO/PBL ERCB). Results: One hundred and ninety nine children (95.7%) were blind (BL = Visual Acuity [VA] < 3/60 in the better eye) and 3 had severe visual impairment (SVI = VA < 6/60 to 3/60 in the better eye). Most children had corneal abnormalities as the major anatomical site of SVI/BL (100, 49.5%), however the cause of SVI/BL was unknown in the majority (88, 43.6%). Measles keratitis was the commonest identifiable cause (17.4%) and 88 children had avoidable causes of SVI/BL (43.6%). Nearly 16% of children required an optical device and 24.2% required medical attention, with a potential for visual improvement through intervention in 15.8%. Conclusion: Nearly half of the children in schools for the blind in Myanmar had potentially avoidable causes of SVI/BL. With measles being both the commonest identifiable and commonest avoidable cause, the data supports the need for a measles immunization campaign. There is also a need for a dedicated pediatric eye care center with regular ophthalmology visits to the schools, and improved optometric, low vision and orientation and mobility services in Myanmar.

30 October 2012 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
JAJames Sunter Muecke, AM
James Sunter Muecke, AM
DSDavid It Sia
David It Sia
HNHenry Newland
Henry Newland
RCRobert J Casson
Robert J Casson
DSDinesh Selva
Dinesh Selva